Source Health Economics
  • Home
  • Services
    • Economic Modelling & Data Analysis
    • Evidence Generation
    • Market Access and Value Communication
    • Health Technology Assessment
    • Commercialisation and Pricing Strategy
    • Training
  • Team
  • Insights
  • Join us
  • Get in touch
Select Page
RAISE guidance – maintaining SLR standards in an AI-assisted future

RAISE guidance – maintaining SLR standards in an AI-assisted future

by Dom Partridge | Oct 21, 2025 | Uncategorised

Written by Gwennie Ogilby (Associate Systematic Review Analyst) and Tom Metcalf (Senior Systematic Review Analyst)   Systematic literature reviews (SLRs) are considered one of the strongest forms of evidence to guide healthcare policy and inform future research....
Thought Piece: How do we Reconcile Commoditisation and Strategic Value in Market Access?

Thought Piece: How do we Reconcile Commoditisation and Strategic Value in Market Access?

by Dom Partridge | Oct 16, 2025 | Uncategorised

Written by Dan Spacie, CEO of SCIRIS   Executive Summary Market access services are undergoing a dual transformation. On one hand, technological advances and procurement pressures are driving commoditisation—standardising deliverables and compressing margins. On...
Newborn genome screening: implications for health technology assessments of new orphan drugs

Newborn genome screening: implications for health technology assessments of new orphan drugs

by Dom Partridge | Sep 5, 2025 | Uncategorised

Written by Luke Parkes   Introduction Newborn screening (NBS) is an impactful public health initiative that enables the diagnosis of severe conditions in asymptomatic infants at birth. Typically, NBS programmes include testing for a select number of metabolic and...
Navigating the complexities of economic evaluation for health technology assessment in dermatology

Navigating the complexities of economic evaluation for health technology assessment in dermatology

by Dom Partridge | Jul 8, 2025 | Uncategorised

Written by Benjamin Clark   As the body’s largest organ, the skin is affected by a vast number of diseases, with over 3,000 distinct dermatological conditions impacting more than 1.8 billion individuals globally at any time (1). With the prevalence of chronic...
NICE refines the HST routing criteria: What you need to know

NICE refines the HST routing criteria: What you need to know

by Dom Partridge | May 30, 2025 | Uncategorised

Written by Brian O’Toole   The National Institute for Health and Care Excellence (NICE) Highly Specialised Technologies (HST) programme is designed to evaluate innovative treatments for rare and complex conditions. On 19th March 2025, NICE announced several...
Systematic review case study: scoping research to identify comparators

Systematic review case study: scoping research to identify comparators

by Dom Partridge | May 29, 2025 | Uncategorised

Written by Sneha Bhadti and David Pritchett   Establishing a list of relevant comparators at the protocol development stage is a vital step in the systematic literature review (SLR) process. Scoping research during this stage can help identify comparators to...
« Older Entries
Next Entries »

London

175 High Holborn
London
WC1V 7AA

Oxford

Floor 2, 226 Banbury Road, Summertown, Oxford, OX2 7BY
+44 (0) 1865 920 567

Connect

Connect with us on LinkedIn

  • © Source Market Access Ltd t/a Source Health Economics
  • Cookies
  • Website by Herd

Company registration number: 10284529 | VAT number: GB248 0293 06

Cookies Policy

Our Website uses cookies to improve your experience. Please visit our Cookies page for more information about cookies and how we use them.

Close